Guillain-Barré syndrome following hepatitis B vaccination

Clinical and Experimental Rheumatology

Volumn 22, Issue 6, 2004, Pages 767-770

  Khamaisi, Mogher ^a   Shoenfeld, Y ^b   Orbach, H ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Engerix; Guillain Barre syndrome; Immunization; Polyradiculoneuropathy; Recombinant vaccine; Vaccination

Indexed keywords

ATORVASTATIN; CALCIUM; ENGERIX; FOLIC ACID; HEPATITIS B SURFACE ANTIBODY; IMMUNOGLOBULIN; LERCANIDIPINE; RECOMBINANT HEPATITIS B VACCINE;

ABDOMINAL PAIN; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; FEMALE; GUILLAIN BARRE SYNDROME; HEMODIALYSIS; HEPATITIS B; HUMAN; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LUNG FUNCTION; MUSCLE WEAKNESS; PRIORITY JOURNAL; SEPTIC SHOCK;

FEMALE; GUILLAIN-BARRE SYNDROME; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MIDDLE AGED; VACCINES, SYNTHETIC;

EID: 11044238611     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MELNICK SC, FLEWETT TH: Role of infection in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1964; 27: 395-407.
2. HAHN AF: Guillain Barre' syndrome. Lancet 1998; 352: 635-41.
3. YUKI N: Infectious origin of, and the molecular mimicry in, Guillain-Barré and Fisher' syndromes. Lancet infectious Diseases 2001; 1: 26-37.
4. TERRYBERRY JS, SHOENFELD Y, GILBURD B et al.: Myelin-and microbe-specific antibodies in Guillain-Barré syndrome. J Clin Lab Anal 1995; 9: 308-19.
5. SCHWERER B: Antibodies against gangliosides: a link between preceeding infection and immunopathogenesis of Guillain Barré syndrome. Microbes Infect 2002; 4: 373-84.
6. LISAK RP, MITCHELL M, ZWEIMAN B, ORRECHIO E, ASBURY AK: Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977; 1: 72-8.
7. ROBSON MG, WALPORT MJ, DAVIES KA: Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol 1994; 33: 1074-7.
8. ROPPER AH, VICTOR M: Influenza vaccination and Guillain-Barré syndrome. N Engl J Med 1998; 339: 1845-6.
9. MORI M, KUWABARA S, MIYAKE M et al.: Haemophilus influenzae infection and Guillain-Barré syndrome. Brain 2000; 128: 2171-8.
10. SHOENFELD Y, ARON-MAOR A: Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J Autoimmun 2000; 14: 1-10.
11. SCONBERGER LB, BREGMAN DJ, SULIVAN-BOLYAI JZ et al.: Guillain-Barré syndrome following vaccination in the national influenza immunization program, United-States, 1976-1977. Am J Epidemiol 1979; 110: 105-23.
12. SAFRANEK TJ, LAWRENCE DN, KURTLAND LT et al.: Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two state study: Expert neurology group. Am J Epidemiol 1991; 133: 940-51.
13. LASKY T, TERRACCIANO GJ, MAGDER L et al.: The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-802.
14. Centers for Disease Control and Prevention: The safety of hepatitis B virus vaccine. MMWR 1983; 32: 134-6.
15. SHAW FE Jr, GRAHAM DJ, GUESS HA et al.: Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol 1988; 127: 337-52.
16. TUOHY PG: Guillain-Barré syndrome following immunisation with synthetic hepatitis B vaccine. N Z Med J 1989; 102: 114-5.
17. McMAHON BJ, HELMINIAK C, WAINWRIGHT RB, BULKOW L, WAINWRIGHT K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992; 92: 254-7.
18. KAKAR A, SETHI PK: Guillain Barré syndrome associated with hepatitis B vaccination. Indian J Pediatr 1997; 64: 710-2.
19. CREANGE A, TEMAM G, LEFAUCHEUR JP: Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999; 30: 143-6.
20. SINSAWAIWONG S, THAMPANITCHAWONG P: Guillain-Barré syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai 2000; 83: 1124-6.
21. SINDERN E, SCHRODER JM, KRISMANN M, MALIN JP: Inflammatory polyradiculoneuropathy with spinal cord involvement and letal outcome after hepatitis B vaccination. J Neurol Sci 2001; 186: 81-5.
22. SETI NK, REDDI R, ANAND I, SETHI PK: Gulliane Barré syndrome following vaccination with hepatitis B vaccine. JAPI 2002; 50: 989.
23. WRAITH DC, GOLDMAN M, LAMBERT PH: Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 362:1659-66.
24. PENNER E, MAIDA E, NAMOLI B, GANGL A: Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barré syndrome. Gastroenterology 1982; 82: 576-80.
25. TSUKADA N, KOH CS, INOUE A, YANAGISAWA N: Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen. J Neurol Sci 1987; 77: 203-16.
26. Van SORGE NM, van der POL WL, JANSEN MD, van den BERG LH. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome. Autoimmunity Review 2004; 3: 61-68.
27. GROTTO I, MANDEL Y, EPHROS M, ASHKENAZI I, SHEMER J: Major adverse reactions to yeast-derived hepatitis B vaccines - a review. Vaccine 1998; 16:329-34.